PhilippeSzaparyMDMSCE

Internal Medicine • Philadelphia, PA

Cardiology

Vice President, Immunology Clinical Development at Janssen, Pharmaceutical Companies of Johnson and Johnson. Preventative Cardiology

Join to view full profile

Dr. Szapary is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Szapary's full profile

Already have an account?

Office
3400 Civic Center Blvd
# E
Philadelphia, PA 19104
Phone+1 215-615-4949

Education & Training

University of California (San Francisco)Residency, Internal Medicine, 1994 - 1997
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1994

Certifications & Licensure

PA State Medical License 1997 - 2024

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Safety and Effectiveness of Flaxseed for Reducing High Cholesterol Start of enrollment: 2003 Jan 01
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

223 citations
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
Howard Sofen, Stacy Smith, Robert Matheson, Craig L. Leonardi, Cesar Calderon
The Journal of Allergy and Clinical Immunology. 2014-04-01
103 citations
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from poole...
Kenneth B. Gordon, Kim A. Papp, Richard G. Langley, Vincent T. Ho, Alexa B. Kimball
Journal of the American Academy of Dermatology. 2012-05-01
152 citations
Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patient...
Tsen-Fang Tsai, Ji-Chen Ho, Michael Song, Philippe Szapary, Cynthia Guzzo
Journal of Dermatological Science. 2011-09-01

Press Mentions

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development ProgramsFebruary 9th, 2019
De Nouvelles Données De Phase 3 Montrent Qu'une Dose Unique De STELARAOctober 10th, 2018
New Phase 3 Data Show Single Dose of STELARAOctober 9th, 2018
Join now to see all

Other Languages

French